The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Gain on disposal of subsidiary | - | 0 | 0 |
| Gain on disposal of property and equipment | - | - | 10,804 |
| Net income | -25,436,108 | 12,833,326 | 23,931,802 |
| Depreciation and amortization expense | -1,340,182 | 746,211 | 1,264,405 |
| Non-cash lease expense | -2,015,965 | 1,251,045 | 2,185,744 |
| Provision for (reversal of) credit losses | -337,316 | 22,211 | 283,752 |
| Stock-based compensation | - | 0 | - |
| Fair value change of long-term investments | -804,777 | 1,108,999 | -384,523 |
| Gain on redemption of life insurance policies | -8,746,138 | 0 | 8,746,138 |
| Gain on disposal of property and equipment | -414,167 | 414,167 | - |
| Change in fair value of cryptocurrencies | - | 34,404 | 111,632 |
| Deferred income taxes | -10,190,708 | 1,651,252 | 7,452,983 |
| Accounts receivable-Nonrelated Party | -456,710 | 294,739 | 789,577 |
| Accounts receivable-Related Party | -21,210,351 | 10,992,577 | 17,039,113 |
| Inventories | -177,591 | -983,024 | 717,972 |
| Finance lease receivables - related parties | -9,491,864 | 2,744,645 | 6,482,967 |
| Customer loans receivable | 8,882,916 | -4,071,560 | -8,081,703 |
| Prepaid expenses and other current assets | -2,809,948 | 831,470 | 1,349,225 |
| Long-term prepayments | 250,074 | -69,678 | -211,988 |
| Other assets | 143,874 | 8,298 | -85,907 |
| Accounts payable | -65,501 | 1,384,721 | 1,165,217 |
| Accounts payable - related parties | -2,259,003 | -311,551 | 2,455,865 |
| Notes payables - related parties | 12,759,536 | -7,727,966 | -5,031,570 |
| Advances from customers-Nonrelated Party | -548,162 | 530,781 | -369,616 |
| Advances from customers-Related Party | 4,404,068 | -3,106,953 | -2,363,891 |
| Income tax payable | 19,690,200 | -13,905,629 | -6,030,526 |
| Operating lease liabilities | 2,215,171 | -1,364,489 | -2,275,398 |
| Accrued liabilities and other current liabilities | 4,639,883 | -1,588,436 | -2,508,035 |
| Proceeds from redemption of life insurance policies | - | 0 | 17,735,717 |
| Other liabilities | 30,733 | -4,548 | -88,593 |
| Advances to related parties | - | 0 | 0 |
| Net cash provided by operating activities | 36,527,364 | -20,884,258 | -6,411,168 |
| Purchase of property and equipment | -478,489 | 43,053 | 560,431 |
| Purchase of convertible note | - | 0 | 0 |
| Purchases of cryptocurrencies | - | 0 | 424,250 |
| Payments made on behalf of related parties | - | 4,260 | 1,836,541 |
| Prepayments for property and equipment | -414,698 | 133,217 | 705,351 |
| Cash paid for acquisition of subsidiary, net of cash acquired | - | 14,861,858 | - |
| Purchase of long-term investments | -654,070 | 1,515 | 652,555 |
| Long-term loans to others | 14,514 | -1,380 | -13,134 |
| Repayments from related parties | -1,911,440 | 1,841,440 | 70,000 |
| Disposal of subsidiary, net of cash disposed of | - | 0 | 0 |
| Repayments from others | 53,088 | -17,621 | -56,307 |
| Proceeds from disposal of property and equipment | -2,755,983 | 1,027,747 | 1,728,236 |
| Net cash used in investing activities | -3,767,548 | -12,158,475 | 15,397,998 |
| Borrowings from long-term loans | - | 14,851,980 | - |
| Borrowings from related parties | -15,000 | 0 | 15,000 |
| Proceeds from reverse recapitalization, net of transaction costs | - | 0 | - |
| Proceeds from exercise of stock warrants | - | 0 | - |
| Repayments of bank and other borrowings | -1,060,605 | -647,618 | -74,256 |
| Repurchase of common stock | - | 2,584,735 | 2,415,262 |
| Repayments of finance lease liabilities | -273,325 | 32,506 | 278,097 |
| Deemed contribution in connection with price modification on disposal of property and equipment | - | 0 | 9,682,277 |
| Repayments to related parties | -24,125 | 18,839 | 27,943 |
| Net cash used in financing activities | -20,312,415 | 11,568,282 | 6,901,719 |
| Effect of exchange rate changes | -11,303,370 | -3,835,113 | 11,808,241 |
| Net change in cash and cash equivalents | 1,144,031 | -25,309,564 | 27,696,790 |
| Cash and cash equivalents as of the beginning of the period | 127,431,318 | 125,044,092 | - |
| Cash and cash equivalents as of the end of the period | 167,305,095 | 127,431,318 | - |
SBC Medical Group Holdings Inc (SBC)
SBC Medical Group Holdings Inc (SBC)